Collaborators
Professor Saeed Hamid, Agha Khan University, Karachi, Pakistan, Liver Cancer - joint Wellcome application, 2013
Professor David Jones, University of Newcastle, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017
Dr Gideon Hirschfield, University of Birmingham, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017
Dr George Mells, Cambridge University, Primary Biliary Cirrhosis: MRC STRATIFIED MEDICINE GRANT ON PRIMARY BILIARY CIRRHOSIS: (joint with Newcastle, Birmingham and Cambridge £5,500,000 (£500,000 to Imperial) July 2013-July 2017 (with Professor David Jones, Newcastle as PI)., 2013 - 2017
Professor Hidekatsu Kuroda, Iwate Medical School, Morioka, Japan, Hepatic Encephalopathy. Professor Kuroda is coming to Imperial on a two year sabbatical to work in our research team, 2012
Professor Abdusamad Dustov, Institute of Gastroenterology, Dushanbe, Tajikistan, ASSOCIATION OF PHYSICIANS OF GREAT BRITAIN AND IRELAND: £15,000 - Overseas Development Grant: for study on metabonomics of hepatocellular carcinoma in aTajik population with chronic hepatitis B., 2012
Professor Lewis RobertsProfessor Gregory Gores, Mayo Clinic, Rochester, Minnesota, USA, Cholangiocarcinoma. Abigail Zabron in our Research Group won the Sheila Sherlock Award from the Royal College of Physicians in 2011 to unertake collaborative work., 2011
Professor Jasmohan Bajaj, Virginia Commonwealth University, Hepatic Encephalopathy: CoI on a NIH grant, 2011
Professor Mourtalla Ka, Thies Medical School, Thies, Senegal, PROLIFICA EU-Framework 7 grant: Prevention of Liver Fibrosis and Liver Cancer in Africa, 2011
Professor Tumani Corrah, Dr Umberto D'Alessandro, MRC Gambia, PROLIFICA EU-Framework 7 Grant on liver fibrosis and liver cancer in Africa, 2011
Benedikt Kessler, University of Oxford, Hepatocellular carcinoma biomarkers, 2011
Professor Souleymanne Mboup, Le Dantec Hospital, Dakar, Senegal, PROLIFICA EU Frameork 7 Grant: Prevention of Liver Fibrosis and Liver Cancer in Africa., 2011
Dr Debbie ShawcrossProfessor Julia Wendon, King's College London, Acute Liver Failure and Hepatic EncephalopathyWELLCOME TRUST: £150,000: “ACUTE LIVER FAILURE AND HEPATIC ENCEPHALOPATHY” October 2010-October 2012 to fund post-doctoral fellow: Dr Mark McPhail., 2010
Professor Paiboon Sithithaworn and team, Khon Kaen University Liver Fluke and Cholangiocarcinoma Centre, Liver fluke and cholangiocarcinoma biomarkers (part of the Wellcome Global Centre at Imperial), 2010
Professor Kirsten Muri Boberg, University of Oslo, Norway/Oslo University Hospital, Cholangiocarcinoma, 2010
Professor Mamun Al Mahtab, Institute of Hepatology, Bangabandhu Sheikh Mujib MEdical University, Dhaka, Bangladesh, liver cancer, viral hepatitis, metabonomics, 2006
Dr Edith Okeke, Jos University Teaching Hospital, Jos, Plateau State, Nigeria, PROLIFICA EU-Framework 7 Grant on liver fibrosis and liver cancer in Africa, 2006
Dr Sara MontagneseProfessor Piero Amodio, University of Padova, Hepatic Encephalopathy. Collaboration through ISHEN, 2006
Professor Imam Waked, National Liver Institute, Menoufiya, Egypt, Viral hepatitis, liver cancer and cholangiocarcinoma. We have hosted several Egyptian MD students (Asmaa Ibrahim Gomaa, Mohamed Saad, Gamal Badra) - one of whom was the beneficiary of a Royal Society Fellowship, 2006
Professor Margaret Bassendine, Newcastle University, 6. MEDICAL RESEARCH COUNCIL: £868,000 March 2007 – February 2011: “Hepatitis C Virus: Host-Lipid Interactions – A novel Application for Lipid Modulating Agents” G0502028. This study on viral kinetics and lipoprotein profiles will be undertaken on a group of patients receiving fish oils and statins – which experimentally alter the host susceptibility to continued viral infection. (co-grant holders: Professor M Bassendine, Professor HC Thomas, Dr G Toms)., 2004
Professor Karin Weissenborn, University of Hannover, Hepatic Encephalopathy, 2002
Guest Lectures
fMRI in Hepatic Encephalopathy, European Association for the Study of the Liver, Amsterdam, Netherlands, 2013
Non-Surgical Treatment of Cholangiocarcinoma, European Association for the Study of the Liver, Barcelona, 2012
PROLIFICA project, European Association for the Study of the Liver:, Barcelona, Spain, 2012
Biomarkers of Liver Fibrosis, Bangladesh Liver Association, Dhaka, Bangladesh, 2010
“Imaging of Basal Ganglia”, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) meeting,, Montreal, Canada,, 2010
Imaging in Hepatic Encephalopathy, Japanese Society of Hepatic Encephalopathy, Tokyo, Japan, 2010
Hepatocellular Carcinoma: Diagnosis and Surveillance Strategies., Norwegian National Liver Disease Meeting, Oslo, Norway, 2010
Imaging of Non-Alcoholic Fatty Liver Disease (State-of-the-Art), European Association for the Study of the Liver: monothematic conference on NAFLD, Bologna, Italy, 2009
“Liver Biochemistry in vivo”, British Association for the Study of the Liver., London, UK, 2009
PET and Imaging in Hepatic Encephalopathy, Japanese Society of Hepatic Encephalopathy, Morioka, Japan, 2009
“Non-invasive Assessment of Liver Fibrosis”, British Viral Hepatitis Group, London, King's Fund, London, 2009
PET kinetics in Hepatic Encephalopathy, European Association for the Study of the Liver, (Copenhagen, Denmark)., 2009
"Non-invasive Liver Biopsy Techniques” ;, Royal College of Physicians of London, Advanced Medicine Course,, Royal College of Physicians of London, 2009
Cholangiocarcinoma Epidemiology, Royal Society of Medicine, Royal Society of Medicine, London, 2009
Hepatitis C Virus and its Cerebral Effects, International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) , ., Padova, Italy, 2008
Hepatitis C and the Brain., EISH Meeting, Prague, Czech Republic, 2007
Update on hepatic encephalopathy., European Association for the Study of the Liver, Barcelona, Spain, 2007
Imaging in Liver Disease, University of California at San Diego, San Diego, USA, University of California at San Diego, San Diego, USA, 2006
“Hepatitis C and the Brain – What to measure?”, International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) ,, Dusseldorf, 2005
Royal College of Physicians Regional Lecture (New Imaging Techniques in the Liver), Royal College of Physicians, 2004
“Extrahepatic manifestations of Hepatitis C”, NIH Single Topic Conference, Washington DC October 2003, NIH, Bethesda, Maryland, USA, 2003
"Cholangiocarcinoma: An Increasing Problem?" Keynote Address, British Society of Gastroenterology, Glasgow, 2001
Linacre Lecture, Royal College of Physicians, 2000
Research Staff
Research Student Supervision
Bak-Bol,A, Meta-analysis of Hepatic Encephalopathy Treatments
Cook,N, Psychometric Testing in Hepatic Encephalopathy
Jakubova,R, Proteomics in Cholangiocarcinoma
Leahy,M, Audit of Hepatocellular Carcinoma Practice
Patel,D, Ultrasound Microbubbles in Liver Disease
Patel,M, Lactulose withdrawal in Hepatic Encephalopathy
Posner,H, Projects on viral hepatitis in Gambia (PROLIFICA)
Ratneswaran,M, Urinary Metabonomics of Hepatic Encephalopathy
Senvar,N, Meta-analysis of Hepatic Encephalopathy Treatment Interventions with Psychometric Testing